IPCALAB1,972.10

Ipca Laboratories Ltd.

· Pharma & Health
₹ CrorePeersTORNTPHARMALKEMJBCHEPHARMABBOTINDIAAJANTPHARMANTHEMGLAXOMEDANTAMcap ₹50,032 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment4,339.54,068.94,440.64,440.6
+ Capital Work-in-Progress323.6616.2761.6761.6
+ Goodwill90.690.682.882.8
+ Other Intangibles123.3107.1103.3103.3
+ Intangibles under Development19.35.611.511.5
+ Investments (Equity Method)157.0191.0183.6183.6
+ Non-current Investments146.625.326.526.5
+ Long-term Loans88.632.414.514.5
+ Other Non-current Financial Assets85.999.995.295.2
Non-current Financial Assets321.1157.6136.2136.2
+ Deferred Tax Assets4.216.920.520.5
+ Other Non-current Assets183.6238.0253.0253.0
Total Non-current Assets5,562.45,492.05,993.35,993.3
Current Assets
+ Inventories2,471.32,560.42,731.02,731.0
+ Current Investments558.4763.4633.4633.4
+ Trade Receivables1,686.51,873.82,014.32,014.3
+ Cash & Cash Equivalents208.9167.2437.1437.1
+ Other Bank Balances87.9177.1127.5127.5
+ Short-term Loans9.442.849.849.8
+ Other Current Financial Assets76.738.517.717.7
Current Financial Assets2,627.93,062.73,279.83,279.8
+ Other Current Assets436.4343.9362.8362.8
Total Current Assets5,535.65,967.06,373.66,373.6
Total Assets11,101.311,760.612,370.212,370.2
Equity
+ Equity Share Capital25.425.425.425.4
+ Other Equity / Reserves6,306.86,923.18,038.48,038.4
Equity — Owners of Parent6,332.26,948.58,063.88,063.8
+ Minority Interest1,394.81,439.81,460.31,460.3
Total Equity7,727.08,388.39,524.19,524.1
Liabilities
+ Borrowings — Non-current580.4543.2109.1109.1
+ Other Non-current Financial Liab39.950.986.986.9
Non-current Financial Liabilities620.3594.1196.0196.0
+ Provisions — Non-current86.896.397.997.9
+ Deferred Tax Liabilities310.5295.0244.9244.9
+ Other Non-current Liabilities1.00.60.40.4
Non-current Liabilities1,018.6986.1539.2539.2
+ Borrowings — Current807.1758.5594.8594.8
+ Trade Payables776.1846.2940.3940.3
+ Other Current Financial Liab362.5375.5467.3467.3
Current Financial Liabilities1,945.71,980.12,002.42,002.4
+ Provisions — Current244.6269.2158.3158.3
+ Current Tax Liabilities43.148.358.858.8
+ Other Current Liabilities122.286.887.587.5
Current Liabilities2,355.62,384.32,306.92,306.9
Total Liabilities3,374.33,372.32,846.12,846.1
Total Equity & Liabilities11,101.311,760.612,370.212,370.2
Assets — additional as-filed lines
+ Biological Assets (other than bearer plants)0.10.30.20.2
+ Non-current Assets Held for Sale3.4301.53.33.3
Liabilities — additional as-filed lines
+ Liabilities of Disposal Group Held for Sale0.01.90.00.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current99.2148.7148.7
+ Dues to Other Creditors — Current747.0791.6791.6
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.